Company Profile | ![]() | 0-9 | ![]() | A | ![]() | B | ![]() | C | ![]() | D | ![]() | E | ![]() | F | ![]() | G | ![]() | H | ![]() | I | ![]() | J | ![]() | K | ![]() | L | ![]() | M | ![]() | N | ![]() | O | ![]() | P | ![]() | Q | ![]() | R | ![]() | S | ![]() | T | ![]() | U | ![]() | V | ![]() | W | ![]() | X | ![]() | Y | ![]() | Z |
WPP plc
(NYSE: WPP)
|
8:00 PM UTC, 04/25/25 | |||
---|---|---|---|---|
Last: $37.08 | Change: -0.43 | %Change: -1.15% | Volume: 210,292 |
11:21 AM EDT, 03/27/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were edging up 0.1% to 1,415.89 late Thursday morning on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by medical device maker EDAP TMS (EDAP) and biopharmaceutical company Genfit (GNFT), which advanced 11% and 2.6% respectively. They were followed by biopharmaceutical company argenx (ARGX) and electronics conglomerate Philips (PHG), which increased 1.9% and 1.8% respectively.
The decliners from continental Europe were led by semiconductor company Sequans Communications (SQNS) and biopharmaceutical company Grifols (GRFS), which fell 3.5% 2.4% respectively. They were followed by telecommunications company Ericsson (ERIC) and pharmaceutical company Novo Nordisk (NVO), which dropped 2.2% and 2.1% respectively.
From the UK and Ireland, the gainers were led by biopharmaceutical companies Bicycle Therapeutics (BCYC) and Mereo BioPharma Group (MREO), which rose 5.5% and 5.1% respectively. They were followed by biopharmaceutical company NuCana (NCNA) and biotech firm Trinity Biotech (TRIB), which were up 5% and 3.5% respectively.
The decliners from the UK and Ireland were led by biopharmaceutical company Biodexa Pharmaceuticals (BDRX), which lost 9.4%. It was followed by financial services company Barclays (BCS) and communications company WPP (WPP), which were down 1.1% and 0.5% respectively.
http://www.mtnewswires.com
Copyright © 2025 MT Newswires. All rights reserved. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.